WGS
GeneDx Holdings·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Signals Analysis
Bullish signal 5
Bearish signal 0
Consensus Rating "Strong Buy"
Ample Liquidity
High Gross Profit Margin
Revenue Beats Expectation
EPS Beats Expectation
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About WGS
Genedx Holdings Corp.
A genetic testing company
333 Ludlow Street, North Tower, 6th Floor Stamford, Connecticut, 06902
--
GeneDx Holdings Corp., a company incorporated in Delaware on July 10, 2020, Sema 4 is a patient-centric health intelligence company dedicated to advancing healthcare through data-driven insights. Sema 4 transforms healthcare by applying artificial intelligence and machine learning to multidimensional, longitudinal clinical and genomic data to build dynamic models of human health and define optimal personalized health trajectories. Centrellis is their innovative health intelligence platform that provides a more comprehensive understanding of disease and health and provides science-driven solutions for the most pressing medical needs.
Earnings Call
Q2/2025
Estimate EPS0.11
Actual EPS0.5
Estimate Revenue85.58M
Actual Revenue102.70M
GeneDx's Q2 2025: Unpacking Contradictions in Revenue Metrics, Medicaid Impact, and NICU Expansion
Jul 29,2025 06:33
Earnings Decrypt
Earnings Decrypt
Q1/2025
Estimate EPS0.09
Actual EPS-0.23
Estimate Revenue79.81M
Actual Revenue87.10M
GeneDx's Q1 2025 Earnings Call: Navigating Contradictions on NICU Growth, Epic Integration, and Margins
May 06,2025 07:34
Earnings Decrypt
Earnings Decrypt
Company Financials
EPS
WGS has released its 2025 Q3 earnings. EPS was reported at 0.49, versus the expected 0.42, beating expectations. The chart below visualizes how WGS has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
WGS has released its 2025 Q3 earnings report, with revenue of 116.74M, reflecting a YoY change of 51.86%, and net profit of -7.63M, showing a YoY change of 8.14%. The Sankey diagram below clearly presents WGS's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
